The O-methylated isoflavone, formononetin, inhibits human ovarian cancer cell proliferation by sub G0/G1 cell phase arrest through PI3K/AKT and ERK1/2 inactivation.

MLA

Park, Sunwoo, et al. “The O-Methylated Isoflavone, Formononetin, Inhibits Human Ovarian Cancer Cell Proliferation by Sub G0/G1 Cell Phase Arrest through PI3K/AKT and ERK1/2 Inactivation.” Journal of Cellular Biochemistry, vol. 119, no. 9, Sept. 2018, pp. 7377–87. EBSCOhost, https://doi.org/10.1002/jcb.27041.

APA

Park, S., Bazer, F. W., Lim, W., & Song, G. (2018). The O-methylated isoflavone, formononetin, inhibits human ovarian cancer cell proliferation by sub G0/G1 cell phase arrest through PI3K/AKT and ERK1/2 inactivation. Journal of Cellular Biochemistry, 119(9), 7377–7387. https://doi.org/10.1002/jcb.27041

Chicago

Park, Sunwoo, Fuller W Bazer, Whasun Lim, and Gwonhwa Song. 2018. “The O-Methylated Isoflavone, Formononetin, Inhibits Human Ovarian Cancer Cell Proliferation by Sub G0/G1 Cell Phase Arrest through PI3K/AKT and ERK1/2 Inactivation.” Journal of Cellular Biochemistry 119 (9): 7377–87. doi:10.1002/jcb.27041.